Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Helius Medical Technologies Inc HSDT

Healthcare Medical Devices
Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing... see more

Recent & Breaking News (NDAQ:HSDT)

Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services' Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices

GlobeNewswire January 20, 2021

Helius Medical Technologies, Inc. Regains Compliance with Nasdaq Listing Standards

GlobeNewswire January 19, 2021

Helius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor Conference

GlobeNewswire January 15, 2021

Helius Medical Technologies, Inc. Submits Response to U.S. FDA in Pursuit of De Novo Classification and Clearance of the PoNS(TM) Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis

GlobeNewswire January 11, 2021

Helius Medical Technologies, Inc. Comments on Unusual Market Activity

GlobeNewswire January 5, 2021

Helius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in January

GlobeNewswire January 4, 2021

Helius Medical Technologies, Inc. Announces Reverse Stock Split

GlobeNewswire December 31, 2020

Helius Medical Technologies, Inc. Reports Third Quarter of Fiscal Year 2020 Financial Results

GlobeNewswire November 12, 2020

Helius Medical Technologies, Inc. to Present at Upcoming Investor Conferences in November

GlobeNewswire November 5, 2020

Helius Medical Technologies, Inc. Announces the Expansion to a Total of 27 Authorized PoNS Treatment(TM) Clinic Locations Across Canada

GlobeNewswire November 4, 2020

Helius Medical Technologies to Release Third Quarter of Fiscal Year 2020 Financial Results on November 12, 2020

GlobeNewswire November 2, 2020

Helius Medical Technologies Announces Closing of $3.4 Million Private Placement

GlobeNewswire October 26, 2020

Helius Medical Technologies Announces $3.4 Million Private Placement

GlobeNewswire October 21, 2020

Helius Medical Technologies, Inc. Provides Update on FDA's Review of its Request for De Novo Classification and Clearance of the PoNS(TM) Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis

GlobeNewswire October 19, 2020

Helius Medical Technologies, Inc. Announces Partnership with Breakthrough Health for Multiple Sclerosis Insights

GlobeNewswire October 14, 2020

Helius Medical Technologies, Inc. Announces Formation of Multiple Sclerosis Scientific Advisory Board

GlobeNewswire October 8, 2020

Helius Medical Technologies, Inc. Announces Publication of Peer-Reviewed Study: Translingual Neural Stimulation with the Portable Neuromodulation Stimulator (PoNS(TM)) Induces Structural Changes Leading to Functional Recovery in Patients with Mild-to-Moderate Traumatic Brain Injury

GlobeNewswire September 8, 2020

Helius Medical Technologies, Inc. to Present at Three Upcoming Investor Conferences in September

GlobeNewswire August 31, 2020

Helius Medical Technologies, Inc. Announces Departure of President, Chief Executive Officer and Chairman Philippe Deschamps; Board of Directors Appoints Dane C. Andreeff as Interim President and Chief Executive Officer and Appoints Blane Walter as Chairman of the Board of Directors

GlobeNewswire August 25, 2020

Helius Medical Technologies, Inc. Reports Second Quarter of Fiscal Year 2020 Financial Results

GlobeNewswire August 12, 2020